Binding of apolipoprotein A-I and acetaldehyde-modified apolipoprotein A-I to liver extracellular matrix

Hepatology

Volumn 23, Issue 5, 1996, Pages 1232-1238

  Paradis, Valerie ^a,c   Mathurin, Phillipe ^b,c   Ratziu, Vlad ^c   Poynard, Thierry ^b,c   Bedossa, Pierre ^a,c  

^a BICÊTRE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ALCOHOL; APOLIPOPROTEIN A1; BOVINE SERUM ALBUMIN; FIBRONECTIN;

ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

ACETALDEHYDE; APOLIPOPROTEIN A-I; COLLAGEN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; LIVER; LIVER CIRRHOSIS, ALCOHOLIC; PROTEIN BINDING; SERUM ALBUMIN, BOVINE;

EID: 85045533760     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230543     Document Type: Article

References (24)

1. Schaefer EJ, Foster DM, Jenkins LL, Lindgren FT, Herman L, Levy RI, Brewer HB. The composition and metabolism of high density lipoprotein subfractions. Lipids 1979;14:511-522.
2. Miller GJ. High density lipoproteins and atherosclerosis. Annu Rev Med 1980;31:97-108.
3. Poynard T, Abella A, Pignon JP, Naveau S, Leluc R, Chaput JC. Apolipoprotein A-I and alcoholic liver disease. HEPATOLOGY 1987;6:1391-1395.
4. Bedossa P, Poynard T, Abella A, Aubert A, Pignon JP, Naveau S, Leluc R, et al. Apolipoprotein A-I is a serum and tissue marker of liver fibrosis in alcoholic patients. Alcohol Clin Exp Res 1989;13:829-833.
5. Poynard T, Aubert A, Bedossa P, Abella A, Naveau S, Paraf F, Chaput JC. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991;100:1397-1402.
6. Bedossa P, Poynard T, Abella A, Paraf F, Lemaigre G, Martin ED. Localization of apolipoprotein A-I and apolipoprotein A-II in normal and atherosclerotic arteries. Arch Pathol Lab Med 1989;113:777-780.
7. Hoff HF, Heideman CL, Jackson RL, Bayardo RJ, Kim H-S, Gotto AM. Localization patterns of plasma apolipoproteins in human atherosclerotic lesions. Circ Res 1975;37:72-79.
8. Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Lipoprotein-acid-mucopolysaccharide complexes of human atherosclerotic lesions. Biochem Biophys Acta 1975;338:58-63.
9. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 1990;10:1-10.
10. Gressner AM. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops and extracellular matrix molecules. Z Gastroenterol 1992;30:5-16.
11. Salonen EM, Saksela O, Vartio T, Vaheri A, Nielsen LS, Zeuthen J. Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem 1985;260:12302-12307.
12. Vartio T, Salonen EM, De Petro G, Barlati S, Miggiano V, Stahli V, Virgallita G, et al. Monoclonal antibody against the N-terminal end of human plasma fibronectin. Biochemistry 1983;215:147-151.
13. Mooradian DL, Lucas RC, Weatherbee JA, Furcht LT. Transforming growth factor β1 bind to immobilized fibronectin. J Cell Biochem 1989;41:189-200.
14. Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a hematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987;326:403-405.
15. Lortat-Jacob H, Kleinman HK, Grimaud JA. High affinity binding of Interferon to a basement membrane complex (Matrigel). J Clin Invest 1991;87:878-883.
16. Jennett RB, Tuma DJ, Sorrell MF. Effects of acetaldehyde on hepatic proteins. In: Popper H, Schaffner F, eds. Progress in liver diseases. Vol IX. Philadelphia: Saunders, 1990:325-333.
17. Tuma DJ, Jennett RB, Sorrell MF. The interaction of acetaldehyde with tubulin. Ann N Y Acad Sci 1987;492:277-286.
18. Behrens UJ, Hoerner M, Lasker JM, Lieber CS. Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo. Biochem Biophys Res Commun 1988;154:584-590.
19. Jukkola A, Niemelä O. Covalent binding of acetaldehyde to type III collagen. Biochem Biophys Res Commun 1989;159:163-169.
20. Stevens VJ, Fantl WJ, Newman CB, Sims RV, Cerami A, Peterson CM. Acetaldehyde adducts with hemoglobin. J Clin Invest 1981;67:361-369.
21. Lin RC, Lumeng L. Further studies on the 37 kD liver protein-acetaldehyde adduct that forms in vivo during chronic alcohol ingestion. HEPATOLOGY 1989;10:807-814.
22. Steinbrecher UP, Fisher M, Witzum JI, Curtiss LK. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine. J Lipid Res 1984;25:1109-1116.
23. Holstege A, Bedossa P, Poynard T, Kollinger M, Chaput JC, Houglum K, Chojkier M. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: localization and association with progression of liver fibrosis. HEPATOLOGY 1994;19:367-373.
24. Palinski W, Yla-Herttualaa S, Rosenfeld ME, Butler S, Socher A, Parthasarathy S, Curtiss LK, et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density protein. Arteriosclerosis 1990;10:325-335.